Skin News and Research

RSS

Longer looks: Turning doctors' views of alternative therapies; a male birth control pill; teenagers and tanning beds

Medicine has long decried acupuncture, homeopathy, and the like as dangerous nonsense that preys on the gullible. Again and again, carefully controlled studies have shown alternative medicine to work no better than a placebo. But now many doctors admit that alternative medicine often seems to do a better job of making patients well, and at a much lower cost, than mainstream care — and they're trying to learn from it.

18 Jun 2011

Endocrine Society honors BUSM professor with The Delbert A. Fisher Research Scholar Award

Michael F. Holick, PhD, MD, director of the General Clinical Research Center and professor of medicine, physiology and biophysics at Boston University School of Medicine, is this year's recipient of The Delbert A. Fisher Research Scholar Award from the Endocrine Society for his scholarly work on the history of endocrinology.

18 Jun 2011

Adolescent obese males at risk of cancer later in life: Study

According to a new study, men who are obese as teenagers are at a greater risk of cancer. Researchers claim that the risk remains even among those who lose weight later in life.

17 Jun 2011

Pawlenty aims verbal barb at Romney

On Thursday, GOP presidential hopeful Tim Pawlenty called rival Mitt Romney a "co-conspirator" in the federal health overhaul. He also repeated his call for repealing the measure, and maintained that, when he was governor, he handled health reform "the right way."

17 Jun 2011

'Blue baby' study sheds light on basic biology

A newborn described as a "happy blue baby" because of her bluish skin color but healthy appearance made a small mark in medical history when one of her physicians discovered something new in her genes-the hemoglobin Toms River mutation.

17 Jun 2011

Positive results from etanercept pilot study against dermatomyositis

A multicenter pilot study of etanercept for treatment of dermatomyositis found no major safety concerns and many patients treated with the drug were successfully weaned from steroid therapy.

17 Jun 2011

Hopkins research suggests that blood vessels and support cells may be real targets of treatment for diabetic nerve damage

Blood vessels and supporting cells appear to be pivotal partners in repairing nerves ravaged by diabetic neuropathy, and nurturing their partnership with nerve cells might make the difference between success and failure in experimental efforts to regrow damaged nerves, Johns Hopkins researchers report in a new study.

16 Jun 2011

Healthy diet, antioxidants, critical nutrients and activities may provide the foundation to youthful living

As the baby boomer generation continues to increase in age, so does its passion to remain youthful, both inside and out. Beating the clock is now a multi-faceted, science-driven industry. From its age-old quests to find the elixir of life, to modern exploration of how microcellular activity contributes to metabolic breakdown, scientific research continues to advance its goals to enhance bodily energy, vigour and performance, and fade or stall the visible signs of aging.

16 Jun 2011

Life Technologies introduces CytoTune-iPS Reprogramming Kit

Life Technologies Corporation today announced the launch of CytoTune-iPS Reprogramming Kit -- research technology that provides far improved efficiency over standard methods to develop induced pluripotent stem cells from human somatic cells.

16 Jun 2011

Bristol-Myers Squibb receives FDA approval for Nulojix to prevent organ rejection after kidney transplant

The U.S. Food and Drug Administration today approved Nulojix to prevent acute rejection in adult patients who have had a kidney transplant. The drug is approved for use with other immunosuppressants -- specifically basiliximab, mycophenolate mofetil, and corticosteroids.

16 Jun 2011

FDA issues final rulemaking on testing and labeling of sunscreen products

"FDA's recognition today of the important role sunscreens play in protecting the public not only from sunburn but also from skin cancer and premature aging due to the sun is a very significant victory for public health. The role of UV rays in causing skin damage and the role of sunscreens in protecting against this sun damage are widely acknowledged within the medical and scientific communities, and we're very pleased the agency has taken this critical step.

15 Jun 2011

Leukothera effectively treats psoriasis in humanized mouse xenograft transplantation model

Psoriasis is a persistent, long-lasting chronic skin disease affecting 2-3 percent of the world's population or more than 125 million individuals. For some, it is just a nuisance. For others, it is disabling.

15 Jun 2011

Tubularized incised plate procedure effective for boys with hypospadias

A pediatric urologist at UT Southwestern Medical Center who pioneered a surgical technique for repairing a common birth defect in boys reports the procedure is singularly effective in correcting the problem with few complications.

15 Jun 2011

FDA's new sunscreen regulations will help reduce skin cancer risk

The American Academy of Dermatology Association (Academy) today said that the U.S. Food and Drug Administration's (FDA) new sunscreen regulations will help Americans reduce their risk for skin cancer by guiding them to the most effective sunscreens and advising them on other sun-protection measures.

15 Jun 2011

New FDA rules for sunscreen labels

The U.S. Food and Drug Administration this Tuesday released new rules that specify sunscreens’ labeling. The rules specify which lotions protect the skin and which do not.

15 Jun 2011

Flip-flops and baseball caps could pose a hidden health risk from skin cancer

Cheap, convenient and casual, baseball caps and flip-flops have a trendy charm. Those qualities make them must-wear accessories for teens, outdoor enthusiasts, gardeners or anyone trying to keep cool during the sweltering days of summer.

15 Jun 2011

New ultrasound technique can measure blood pressure at many points in the body

Researchers at Eindhoven University of Technology, together with the Italian company Esaote, have developed a new technique to measure the blood pressure.

15 Jun 2011

Abbott’s CREON receives FDA approval for infant-specific dose

Abbott announced today that the U.S. Food and Drug Administration (FDA) has approved an infant-specific dose of CREON® (pancrelipase) Delayed-Release Capsules to treat exocrine pancreatic insufficiency (EPI) due to cystic fibrosis (CF). The CREON 3,000 units of lipase capsule provides the lowest dosage strength in the class approved by the FDA. This new option will enable more precise dosing titration in accordance with the Cystic Fibrosis Foundation guidelines for infant dosing.

14 Jun 2011

Roundup: States controlled by GOP pass sweeping changes; state budgets still very lean from recession; La. Gov. wrestling with legislature over spending

Republicans controlled all the levers of government in a staggering number of states this year — and it showed. Holding a lock on the governorship and both houses of the legislature in 20 states, GOP conservatives advanced an agenda that may change the face of state government for decades. They honored pledges not to raise taxes by enacting huge spending cuts to balance budgets in Florida and Texas.

14 Jun 2011

Mystic's key manufacturing technology for drug, biologic delivery systems receives U.S. patent

Mystic Pharmaceuticals, Inc. announces today that it has been granted U.S. Patent No. 7,963,089, "Deep Draw Container Forming Method," for a key manufacturing technology of its VersiDoser and VRx2 drug and biologic delivery systems.

13 Jun 2011

Skin News and Research

Longer looks: Turning doctors' views of alternative therapies; a male birth control pill; teenagers and tanning beds

Endocrine Society honors BUSM professor with The Delbert A. Fisher Research Scholar Award

Adolescent obese males at risk of cancer later in life: Study

Pawlenty aims verbal barb at Romney

'Blue baby' study sheds light on basic biology

Positive results from etanercept pilot study against dermatomyositis

Hopkins research suggests that blood vessels and support cells may be real targets of treatment for diabetic nerve damage

Healthy diet, antioxidants, critical nutrients and activities may provide the foundation to youthful living

Life Technologies introduces CytoTune-iPS Reprogramming Kit

Bristol-Myers Squibb receives FDA approval for Nulojix to prevent organ rejection after kidney transplant

FDA issues final rulemaking on testing and labeling of sunscreen products

Leukothera effectively treats psoriasis in humanized mouse xenograft transplantation model

Tubularized incised plate procedure effective for boys with hypospadias

FDA's new sunscreen regulations will help reduce skin cancer risk

New FDA rules for sunscreen labels

Flip-flops and baseball caps could pose a hidden health risk from skin cancer

New ultrasound technique can measure blood pressure at many points in the body

Abbott’s CREON receives FDA approval for infant-specific dose

Roundup: States controlled by GOP pass sweeping changes; state budgets still very lean from recession; La. Gov. wrestling with legislature over spending

Mystic's key manufacturing technology for drug, biologic delivery systems receives U.S. patent

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News